Total: £ 56.28
Published Date: 2025-05-06 | Pages: 106 | Tables: 109 | Medical Care
The global market for Pharmaceutical Customized R&D and Production Services was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Contract development and manufacturing organizations (CDMOs) provide a wide range of services to the pharmaceutical and biopharmaceutical industries. These services can range from drug development to clinical trial support to manufacturing and more.
North American market for Pharmaceutical Customized R&D and Production Services is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Pharmaceutical Customized R&D and Production Services is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Pharmaceutical Customized R&D and Production Services in Clinical Stage Projects is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Pharmaceutical Customized R&D and Production Services include Haixiang Pharmaceutical, Innovent Biologics, Betta Pharmaceuticals, Jiuzhou Pharmaceutical, Puluo Pharmaceutical, Menohua, Tianyu shares, Aoxiang Pharmaceutical, Hetero, CellMark, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Customized R&D and Production Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Customized R&D and Production Services.
The Pharmaceutical Customized R&D and Production Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharmaceutical Customized R&D and Production Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical Customized R&D and Production Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Haixiang Pharmaceutical
Innovent Biologics
Betta Pharmaceuticals
Jiuzhou Pharmaceutical
Puluo Pharmaceutical
Menohua
Tianyu shares
Aoxiang Pharmaceutical
Hetero
CellMark
R&D Systems
Porton Pharmaceuticals
Kai Laiying
Smart Life
Notai Biotech
Aurobindo Pharma
Lonza Group
Catalent Inc.
Recipharm AB
Jubilant Pharmova Ltd
Patheon Inc. (Thermo Fisher Scientific Inc.)
Boehringer Ingelheim Group
Pfizer CentreSource
Baxter International Inc.
Lonza Group
Segment by Type
Human Medicine
Veterinary Medicine
Segment by Application
Clinical Stage Projects
Commercialization Stage Projects
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmaceutical Customized R&D and Production Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutical Customized R&D and Production Services Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Human Medicine
1.2.3 Veterinary Medicine
1.3 Market by Application
1.3.1 Global Pharmaceutical Customized R&D and Production Services Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Clinical Stage Projects
1.3.3 Commercialization Stage Projects
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical Customized R&D and Production Services Market Perspective (2020-2031)
2.2 Global Pharmaceutical Customized R&D and Production Services Growth Trends by Region
2.2.1 Global Pharmaceutical Customized R&D and Production Services Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Pharmaceutical Customized R&D and Production Services Historic Market Size by Region (2020-2025)
2.2.3 Pharmaceutical Customized R&D and Production Services Forecasted Market Size by Region (2026-2031)
2.3 Pharmaceutical Customized R&D and Production Services Market Dynamics
2.3.1 Pharmaceutical Customized R&D and Production Services Industry Trends
2.3.2 Pharmaceutical Customized R&D and Production Services Market Drivers
2.3.3 Pharmaceutical Customized R&D and Production Services Market Challenges
2.3.4 Pharmaceutical Customized R&D and Production Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical Customized R&D and Production Services Players by Revenue
3.1.1 Global Top Pharmaceutical Customized R&D and Production Services Players by Revenue (2020-2025)
3.1.2 Global Pharmaceutical Customized R&D and Production Services Revenue Market Share by Players (2020-2025)
3.2 Global Pharmaceutical Customized R&D and Production Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Pharmaceutical Customized R&D and Production Services Revenue
3.4 Global Pharmaceutical Customized R&D and Production Services Market Concentration Ratio
3.4.1 Global Pharmaceutical Customized R&D and Production Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Customized R&D and Production Services Revenue in 2024
3.5 Global Key Players of Pharmaceutical Customized R&D and Production Services Head office and Area Served
3.6 Global Key Players of Pharmaceutical Customized R&D and Production Services, Product and Application
3.7 Global Key Players of Pharmaceutical Customized R&D and Production Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceutical Customized R&D and Production Services Breakdown Data by Type
4.1 Global Pharmaceutical Customized R&D and Production Services Historic Market Size by Type (2020-2025)
4.2 Global Pharmaceutical Customized R&D and Production Services Forecasted Market Size by Type (2026-2031)
5 Pharmaceutical Customized R&D and Production Services Breakdown Data by Application
5.1 Global Pharmaceutical Customized R&D and Production Services Historic Market Size by Application (2020-2025)
5.2 Global Pharmaceutical Customized R&D and Production Services Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Pharmaceutical Customized R&D and Production Services Market Size (2020-2031)
6.2 North America Pharmaceutical Customized R&D and Production Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Pharmaceutical Customized R&D and Production Services Market Size by Country (2020-2025)
6.4 North America Pharmaceutical Customized R&D and Production Services Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmaceutical Customized R&D and Production Services Market Size (2020-2031)
7.2 Europe Pharmaceutical Customized R&D and Production Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Pharmaceutical Customized R&D and Production Services Market Size by Country (2020-2025)
7.4 Europe Pharmaceutical Customized R&D and Production Services Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical Customized R&D and Production Services Market Size (2020-2031)
8.2 Asia-Pacific Pharmaceutical Customized R&D and Production Services Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Pharmaceutical Customized R&D and Production Services Market Size by Region (2020-2025)
8.4 Asia-Pacific Pharmaceutical Customized R&D and Production Services Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharmaceutical Customized R&D and Production Services Market Size (2020-2031)
9.2 Latin America Pharmaceutical Customized R&D and Production Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Pharmaceutical Customized R&D and Production Services Market Size by Country (2020-2025)
9.4 Latin America Pharmaceutical Customized R&D and Production Services Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical Customized R&D and Production Services Market Size (2020-2031)
10.2 Middle East & Africa Pharmaceutical Customized R&D and Production Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Pharmaceutical Customized R&D and Production Services Market Size by Country (2020-2025)
10.4 Middle East & Africa Pharmaceutical Customized R&D and Production Services Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Haixiang Pharmaceutical
11.1.1 Haixiang Pharmaceutical Company Details
11.1.2 Haixiang Pharmaceutical Business Overview
11.1.3 Haixiang Pharmaceutical Pharmaceutical Customized R&D and Production Services Introduction
11.1.4 Haixiang Pharmaceutical Revenue in Pharmaceutical Customized R&D and Production Services Business (2020-2025)
11.1.5 Haixiang Pharmaceutical Recent Development
11.2 Innovent Biologics
11.2.1 Innovent Biologics Company Details
11.2.2 Innovent Biologics Business Overview
11.2.3 Innovent Biologics Pharmaceutical Customized R&D and Production Services Introduction
11.2.4 Innovent Biologics Revenue in Pharmaceutical Customized R&D and Production Services Business (2020-2025)
11.2.5 Innovent Biologics Recent Development
11.3 Betta Pharmaceuticals
11.3.1 Betta Pharmaceuticals Company Details
11.3.2 Betta Pharmaceuticals Business Overview
11.3.3 Betta Pharmaceuticals Pharmaceutical Customized R&D and Production Services Introduction
11.3.4 Betta Pharmaceuticals Revenue in Pharmaceutical Customized R&D and Production Services Business (2020-2025)
11.3.5 Betta Pharmaceuticals Recent Development
11.4 Jiuzhou Pharmaceutical
11.4.1 Jiuzhou Pharmaceutical Company Details
11.4.2 Jiuzhou Pharmaceutical Business Overview
11.4.3 Jiuzhou Pharmaceutical Pharmaceutical Customized R&D and Production Services Introduction
11.4.4 Jiuzhou Pharmaceutical Revenue in Pharmaceutical Customized R&D and Production Services Business (2020-2025)
11.4.5 Jiuzhou Pharmaceutical Recent Development
11.5 Puluo Pharmaceutical
11.5.1 Puluo Pharmaceutical Company Details
11.5.2 Puluo Pharmaceutical Business Overview
11.5.3 Puluo Pharmaceutical Pharmaceutical Customized R&D and Production Services Introduction
11.5.4 Puluo Pharmaceutical Revenue in Pharmaceutical Customized R&D and Production Services Business (2020-2025)
11.5.5 Puluo Pharmaceutical Recent Development
11.6 Menohua
11.6.1 Menohua Company Details
11.6.2 Menohua Business Overview
11.6.3 Menohua Pharmaceutical Customized R&D and Production Services Introduction
11.6.4 Menohua Revenue in Pharmaceutical Customized R&D and Production Services Business (2020-2025)
11.6.5 Menohua Recent Development
11.7 Tianyu shares
11.7.1 Tianyu shares Company Details
11.7.2 Tianyu shares Business Overview
11.7.3 Tianyu shares Pharmaceutical Customized R&D and Production Services Introduction
11.7.4 Tianyu shares Revenue in Pharmaceutical Customized R&D and Production Services Business (2020-2025)
11.7.5 Tianyu shares Recent Development
11.8 Aoxiang Pharmaceutical
11.8.1 Aoxiang Pharmaceutical Company Details
11.8.2 Aoxiang Pharmaceutical Business Overview
11.8.3 Aoxiang Pharmaceutical Pharmaceutical Customized R&D and Production Services Introduction
11.8.4 Aoxiang Pharmaceutical Revenue in Pharmaceutical Customized R&D and Production Services Business (2020-2025)
11.8.5 Aoxiang Pharmaceutical Recent Development
11.9 Hetero
11.9.1 Hetero Company Details
11.9.2 Hetero Business Overview
11.9.3 Hetero Pharmaceutical Customized R&D and Production Services Introduction
11.9.4 Hetero Revenue in Pharmaceutical Customized R&D and Production Services Business (2020-2025)
11.9.5 Hetero Recent Development
11.10 CellMark
11.10.1 CellMark Company Details
11.10.2 CellMark Business Overview
11.10.3 CellMark Pharmaceutical Customized R&D and Production Services Introduction
11.10.4 CellMark Revenue in Pharmaceutical Customized R&D and Production Services Business (2020-2025)
11.10.5 CellMark Recent Development
11.11 R&D Systems
11.11.1 R&D Systems Company Details
11.11.2 R&D Systems Business Overview
11.11.3 R&D Systems Pharmaceutical Customized R&D and Production Services Introduction
11.11.4 R&D Systems Revenue in Pharmaceutical Customized R&D and Production Services Business (2020-2025)
11.11.5 R&D Systems Recent Development
11.12 Porton Pharmaceuticals
11.12.1 Porton Pharmaceuticals Company Details
11.12.2 Porton Pharmaceuticals Business Overview
11.12.3 Porton Pharmaceuticals Pharmaceutical Customized R&D and Production Services Introduction
11.12.4 Porton Pharmaceuticals Revenue in Pharmaceutical Customized R&D and Production Services Business (2020-2025)
11.12.5 Porton Pharmaceuticals Recent Development
11.13 Kai Laiying
11.13.1 Kai Laiying Company Details
11.13.2 Kai Laiying Business Overview
11.13.3 Kai Laiying Pharmaceutical Customized R&D and Production Services Introduction
11.13.4 Kai Laiying Revenue in Pharmaceutical Customized R&D and Production Services Business (2020-2025)
11.13.5 Kai Laiying Recent Development
11.14 Smart Life
11.14.1 Smart Life Company Details
11.14.2 Smart Life Business Overview
11.14.3 Smart Life Pharmaceutical Customized R&D and Production Services Introduction
11.14.4 Smart Life Revenue in Pharmaceutical Customized R&D and Production Services Business (2020-2025)
11.14.5 Smart Life Recent Development
11.15 Notai Biotech
11.15.1 Notai Biotech Company Details
11.15.2 Notai Biotech Business Overview
11.15.3 Notai Biotech Pharmaceutical Customized R&D and Production Services Introduction
11.15.4 Notai Biotech Revenue in Pharmaceutical Customized R&D and Production Services Business (2020-2025)
11.15.5 Notai Biotech Recent Development
11.16 Aurobindo Pharma
11.16.1 Aurobindo Pharma Company Details
11.16.2 Aurobindo Pharma Business Overview
11.16.3 Aurobindo Pharma Pharmaceutical Customized R&D and Production Services Introduction
11.16.4 Aurobindo Pharma Revenue in Pharmaceutical Customized R&D and Production Services Business (2020-2025)
11.16.5 Aurobindo Pharma Recent Development
11.17 Lonza Group
11.17.1 Lonza Group Company Details
11.17.2 Lonza Group Business Overview
11.17.3 Lonza Group Pharmaceutical Customized R&D and Production Services Introduction
11.17.4 Lonza Group Revenue in Pharmaceutical Customized R&D and Production Services Business (2020-2025)
11.17.5 Lonza Group Recent Development
11.18 Catalent Inc.
11.18.1 Catalent Inc. Company Details
11.18.2 Catalent Inc. Business Overview
11.18.3 Catalent Inc. Pharmaceutical Customized R&D and Production Services Introduction
11.18.4 Catalent Inc. Revenue in Pharmaceutical Customized R&D and Production Services Business (2020-2025)
11.18.5 Catalent Inc. Recent Development
11.19 Recipharm AB
11.19.1 Recipharm AB Company Details
11.19.2 Recipharm AB Business Overview
11.19.3 Recipharm AB Pharmaceutical Customized R&D and Production Services Introduction
11.19.4 Recipharm AB Revenue in Pharmaceutical Customized R&D and Production Services Business (2020-2025)
11.19.5 Recipharm AB Recent Development
11.20 Jubilant Pharmova Ltd
11.20.1 Jubilant Pharmova Ltd Company Details
11.20.2 Jubilant Pharmova Ltd Business Overview
11.20.3 Jubilant Pharmova Ltd Pharmaceutical Customized R&D and Production Services Introduction
11.20.4 Jubilant Pharmova Ltd Revenue in Pharmaceutical Customized R&D and Production Services Business (2020-2025)
11.20.5 Jubilant Pharmova Ltd Recent Development
11.21 Patheon Inc. (Thermo Fisher Scientific Inc.)
11.21.1 Patheon Inc. (Thermo Fisher Scientific Inc.) Company Details
11.21.2 Patheon Inc. (Thermo Fisher Scientific Inc.) Business Overview
11.21.3 Patheon Inc. (Thermo Fisher Scientific Inc.) Pharmaceutical Customized R&D and Production Services Introduction
11.21.4 Patheon Inc. (Thermo Fisher Scientific Inc.) Revenue in Pharmaceutical Customized R&D and Production Services Business (2020-2025)
11.21.5 Patheon Inc. (Thermo Fisher Scientific Inc.) Recent Development
11.22 Boehringer Ingelheim Group
11.22.1 Boehringer Ingelheim Group Company Details
11.22.2 Boehringer Ingelheim Group Business Overview
11.22.3 Boehringer Ingelheim Group Pharmaceutical Customized R&D and Production Services Introduction
11.22.4 Boehringer Ingelheim Group Revenue in Pharmaceutical Customized R&D and Production Services Business (2020-2025)
11.22.5 Boehringer Ingelheim Group Recent Development
11.23 Pfizer CentreSource
11.23.1 Pfizer CentreSource Company Details
11.23.2 Pfizer CentreSource Business Overview
11.23.3 Pfizer CentreSource Pharmaceutical Customized R&D and Production Services Introduction
11.23.4 Pfizer CentreSource Revenue in Pharmaceutical Customized R&D and Production Services Business (2020-2025)
11.23.5 Pfizer CentreSource Recent Development
11.24 Baxter International Inc.
11.24.1 Baxter International Inc. Company Details
11.24.2 Baxter International Inc. Business Overview
11.24.3 Baxter International Inc. Pharmaceutical Customized R&D and Production Services Introduction
11.24.4 Baxter International Inc. Revenue in Pharmaceutical Customized R&D and Production Services Business (2020-2025)
11.24.5 Baxter International Inc. Recent Development
11.25 Lonza Group
11.25.1 Lonza Group Company Details
11.25.2 Lonza Group Business Overview
11.25.3 Lonza Group Pharmaceutical Customized R&D and Production Services Introduction
11.25.4 Lonza Group Revenue in Pharmaceutical Customized R&D and Production Services Business (2020-2025)
11.25.5 Lonza Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Pharmaceutical Customized R&D and Production Services Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Human Medicine
Table 3. Key Players of Veterinary Medicine
Table 4. Global Pharmaceutical Customized R&D and Production Services Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Pharmaceutical Customized R&D and Production Services Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Pharmaceutical Customized R&D and Production Services Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Pharmaceutical Customized R&D and Production Services Market Share by Region (2020-2025)
Table 8. Global Pharmaceutical Customized R&D and Production Services Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Pharmaceutical Customized R&D and Production Services Market Share by Region (2026-2031)
Table 10. Pharmaceutical Customized R&D and Production Services Market Trends
Table 11. Pharmaceutical Customized R&D and Production Services Market Drivers
Table 12. Pharmaceutical Customized R&D and Production Services Market Challenges
Table 13. Pharmaceutical Customized R&D and Production Services Market Restraints
Table 14. Global Pharmaceutical Customized R&D and Production Services Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Pharmaceutical Customized R&D and Production Services Market Share by Players (2020-2025)
Table 16. Global Top Pharmaceutical Customized R&D and Production Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Customized R&D and Production Services as of 2024)
Table 17. Ranking of Global Top Pharmaceutical Customized R&D and Production Services Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Pharmaceutical Customized R&D and Production Services Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Pharmaceutical Customized R&D and Production Services, Headquarters and Area Served
Table 20. Global Key Players of Pharmaceutical Customized R&D and Production Services, Product and Application
Table 21. Global Key Players of Pharmaceutical Customized R&D and Production Services, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Pharmaceutical Customized R&D and Production Services Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Pharmaceutical Customized R&D and Production Services Revenue Market Share by Type (2020-2025)
Table 25. Global Pharmaceutical Customized R&D and Production Services Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Pharmaceutical Customized R&D and Production Services Revenue Market Share by Type (2026-2031)
Table 27. Global Pharmaceutical Customized R&D and Production Services Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Pharmaceutical Customized R&D and Production Services Revenue Market Share by Application (2020-2025)
Table 29. Global Pharmaceutical Customized R&D and Production Services Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Pharmaceutical Customized R&D and Production Services Revenue Market Share by Application (2026-2031)
Table 31. North America Pharmaceutical Customized R&D and Production Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Pharmaceutical Customized R&D and Production Services Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Pharmaceutical Customized R&D and Production Services Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Pharmaceutical Customized R&D and Production Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Pharmaceutical Customized R&D and Production Services Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Pharmaceutical Customized R&D and Production Services Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Pharmaceutical Customized R&D and Production Services Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Pharmaceutical Customized R&D and Production Services Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Pharmaceutical Customized R&D and Production Services Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Pharmaceutical Customized R&D and Production Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Pharmaceutical Customized R&D and Production Services Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Pharmaceutical Customized R&D and Production Services Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Pharmaceutical Customized R&D and Production Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Pharmaceutical Customized R&D and Production Services Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Pharmaceutical Customized R&D and Production Services Market Size by Country (2026-2031) & (US$ Million)
Table 46. Haixiang Pharmaceutical Company Details
Table 47. Haixiang Pharmaceutical Business Overview
Table 48. Haixiang Pharmaceutical Pharmaceutical Customized R&D and Production Services Product
Table 49. Haixiang Pharmaceutical Revenue in Pharmaceutical Customized R&D and Production Services Business (2020-2025) & (US$ Million)
Table 50. Haixiang Pharmaceutical Recent Development
Table 51. Innovent Biologics Company Details
Table 52. Innovent Biologics Business Overview
Table 53. Innovent Biologics Pharmaceutical Customized R&D and Production Services Product
Table 54. Innovent Biologics Revenue in Pharmaceutical Customized R&D and Production Services Business (2020-2025) & (US$ Million)
Table 55. Innovent Biologics Recent Development
Table 56. Betta Pharmaceuticals Company Details
Table 57. Betta Pharmaceuticals Business Overview
Table 58. Betta Pharmaceuticals Pharmaceutical Customized R&D and Production Services Product
Table 59. Betta Pharmaceuticals Revenue in Pharmaceutical Customized R&D and Production Services Business (2020-2025) & (US$ Million)
Table 60. Betta Pharmaceuticals Recent Development
Table 61. Jiuzhou Pharmaceutical Company Details
Table 62. Jiuzhou Pharmaceutical Business Overview
Table 63. Jiuzhou Pharmaceutical Pharmaceutical Customized R&D and Production Services Product
Table 64. Jiuzhou Pharmaceutical Revenue in Pharmaceutical Customized R&D and Production Services Business (2020-2025) & (US$ Million)
Table 65. Jiuzhou Pharmaceutical Recent Development
Table 66. Puluo Pharmaceutical Company Details
Table 67. Puluo Pharmaceutical Business Overview
Table 68. Puluo Pharmaceutical Pharmaceutical Customized R&D and Production Services Product
Table 69. Puluo Pharmaceutical Revenue in Pharmaceutical Customized R&D and Production Services Business (2020-2025) & (US$ Million)
Table 70. Puluo Pharmaceutical Recent Development
Table 71. Menohua Company Details
Table 72. Menohua Business Overview
Table 73. Menohua Pharmaceutical Customized R&D and Production Services Product
Table 74. Menohua Revenue in Pharmaceutical Customized R&D and Production Services Business (2020-2025) & (US$ Million)
Table 75. Menohua Recent Development
Table 76. Tianyu shares Company Details
Table 77. Tianyu shares Business Overview
Table 78. Tianyu shares Pharmaceutical Customized R&D and Production Services Product
Table 79. Tianyu shares Revenue in Pharmaceutical Customized R&D and Production Services Business (2020-2025) & (US$ Million)
Table 80. Tianyu shares Recent Development
Table 81. Aoxiang Pharmaceutical Company Details
Table 82. Aoxiang Pharmaceutical Business Overview
Table 83. Aoxiang Pharmaceutical Pharmaceutical Customized R&D and Production Services Product
Table 84. Aoxiang Pharmaceutical Revenue in Pharmaceutical Customized R&D and Production Services Business (2020-2025) & (US$ Million)
Table 85. Aoxiang Pharmaceutical Recent Development
Table 86. Hetero Company Details
Table 87. Hetero Business Overview
Table 88. Hetero Pharmaceutical Customized R&D and Production Services Product
Table 89. Hetero Revenue in Pharmaceutical Customized R&D and Production Services Business (2020-2025) & (US$ Million)
Table 90. Hetero Recent Development
Table 91. CellMark Company Details
Table 92. CellMark Business Overview
Table 93. CellMark Pharmaceutical Customized R&D and Production Services Product
Table 94. CellMark Revenue in Pharmaceutical Customized R&D and Production Services Business (2020-2025) & (US$ Million)
Table 95. CellMark Recent Development
Table 96. R&D Systems Company Details
Table 97. R&D Systems Business Overview
Table 98. R&D Systems Pharmaceutical Customized R&D and Production Services Product
Table 99. R&D Systems Revenue in Pharmaceutical Customized R&D and Production Services Business (2020-2025) & (US$ Million)
Table 100. R&D Systems Recent Development
Table 101. Porton Pharmaceuticals Company Details
Table 102. Porton Pharmaceuticals Business Overview
Table 103. Porton Pharmaceuticals Pharmaceutical Customized R&D and Production Services Product
Table 104. Porton Pharmaceuticals Revenue in Pharmaceutical Customized R&D and Production Services Business (2020-2025) & (US$ Million)
Table 105. Porton Pharmaceuticals Recent Development
Table 106. Kai Laiying Company Details
Table 107. Kai Laiying Business Overview
Table 108. Kai Laiying Pharmaceutical Customized R&D and Production Services Product
Table 109. Kai Laiying Revenue in Pharmaceutical Customized R&D and Production Services Business (2020-2025) & (US$ Million)
Table 110. Kai Laiying Recent Development
Table 111. Smart Life Company Details
Table 112. Smart Life Business Overview
Table 113. Smart Life Pharmaceutical Customized R&D and Production Services Product
Table 114. Smart Life Revenue in Pharmaceutical Customized R&D and Production Services Business (2020-2025) & (US$ Million)
Table 115. Smart Life Recent Development
Table 116. Notai Biotech Company Details
Table 117. Notai Biotech Business Overview
Table 118. Notai Biotech Pharmaceutical Customized R&D and Production Services Product
Table 119. Notai Biotech Revenue in Pharmaceutical Customized R&D and Production Services Business (2020-2025) & (US$ Million)
Table 120. Notai Biotech Recent Development
Table 121. Aurobindo Pharma Company Details
Table 122. Aurobindo Pharma Business Overview
Table 123. Aurobindo Pharma Pharmaceutical Customized R&D and Production Services Product
Table 124. Aurobindo Pharma Revenue in Pharmaceutical Customized R&D and Production Services Business (2020-2025) & (US$ Million)
Table 125. Aurobindo Pharma Recent Development
Table 126. Lonza Group Company Details
Table 127. Lonza Group Business Overview
Table 128. Lonza Group Pharmaceutical Customized R&D and Production Services Product
Table 129. Lonza Group Revenue in Pharmaceutical Customized R&D and Production Services Business (2020-2025) & (US$ Million)
Table 130. Lonza Group Recent Development
Table 131. Catalent Inc. Company Details
Table 132. Catalent Inc. Business Overview
Table 133. Catalent Inc. Pharmaceutical Customized R&D and Production Services Product
Table 134. Catalent Inc. Revenue in Pharmaceutical Customized R&D and Production Services Business (2020-2025) & (US$ Million)
Table 135. Catalent Inc. Recent Development
Table 136. Recipharm AB Company Details
Table 137. Recipharm AB Business Overview
Table 138. Recipharm AB Pharmaceutical Customized R&D and Production Services Product
Table 139. Recipharm AB Revenue in Pharmaceutical Customized R&D and Production Services Business (2020-2025) & (US$ Million)
Table 140. Recipharm AB Recent Development
Table 141. Jubilant Pharmova Ltd Company Details
Table 142. Jubilant Pharmova Ltd Business Overview
Table 143. Jubilant Pharmova Ltd Pharmaceutical Customized R&D and Production Services Product
Table 144. Jubilant Pharmova Ltd Revenue in Pharmaceutical Customized R&D and Production Services Business (2020-2025) & (US$ Million)
Table 145. Jubilant Pharmova Ltd Recent Development
Table 146. Patheon Inc. (Thermo Fisher Scientific Inc.) Company Details
Table 147. Patheon Inc. (Thermo Fisher Scientific Inc.) Business Overview
Table 148. Patheon Inc. (Thermo Fisher Scientific Inc.) Pharmaceutical Customized R&D and Production Services Product
Table 149. Patheon Inc. (Thermo Fisher Scientific Inc.) Revenue in Pharmaceutical Customized R&D and Production Services Business (2020-2025) & (US$ Million)
Table 150. Patheon Inc. (Thermo Fisher Scientific Inc.) Recent Development
Table 151. Boehringer Ingelheim Group Company Details
Table 152. Boehringer Ingelheim Group Business Overview
Table 153. Boehringer Ingelheim Group Pharmaceutical Customized R&D and Production Services Product
Table 154. Boehringer Ingelheim Group Revenue in Pharmaceutical Customized R&D and Production Services Business (2020-2025) & (US$ Million)
Table 155. Boehringer Ingelheim Group Recent Development
Table 156. Pfizer CentreSource Company Details
Table 157. Pfizer CentreSource Business Overview
Table 158. Pfizer CentreSource Pharmaceutical Customized R&D and Production Services Product
Table 159. Pfizer CentreSource Revenue in Pharmaceutical Customized R&D and Production Services Business (2020-2025) & (US$ Million)
Table 160. Pfizer CentreSource Recent Development
Table 161. Baxter International Inc. Company Details
Table 162. Baxter International Inc. Business Overview
Table 163. Baxter International Inc. Pharmaceutical Customized R&D and Production Services Product
Table 164. Baxter International Inc. Revenue in Pharmaceutical Customized R&D and Production Services Business (2020-2025) & (US$ Million)
Table 165. Baxter International Inc. Recent Development
Table 166. Lonza Group Company Details
Table 167. Lonza Group Business Overview
Table 168. Lonza Group Pharmaceutical Customized R&D and Production Services Product
Table 169. Lonza Group Revenue in Pharmaceutical Customized R&D and Production Services Business (2020-2025) & (US$ Million)
Table 170. Lonza Group Recent Development
Table 171. Research Programs/Design for This Report
Table 172. Key Data Information from Secondary Sources
Table 173. Key Data Information from Primary Sources
Table 174. Authors List of This Report
List of Figures
Figure 1. Pharmaceutical Customized R&D and Production Services Picture
Figure 2. Global Pharmaceutical Customized R&D and Production Services Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Pharmaceutical Customized R&D and Production Services Market Share by Type: 2024 VS 2031
Figure 4. Human Medicine Features
Figure 5. Veterinary Medicine Features
Figure 6. Global Pharmaceutical Customized R&D and Production Services Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Pharmaceutical Customized R&D and Production Services Market Share by Application: 2024 VS 2031
Figure 8. Clinical Stage Projects Case Studies
Figure 9. Commercialization Stage Projects Case Studies
Figure 10. Pharmaceutical Customized R&D and Production Services Report Years Considered
Figure 11. Global Pharmaceutical Customized R&D and Production Services Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Pharmaceutical Customized R&D and Production Services Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Pharmaceutical Customized R&D and Production Services Market Share by Region: 2024 VS 2031
Figure 14. Global Pharmaceutical Customized R&D and Production Services Market Share by Players in 2024
Figure 15. Global Top Pharmaceutical Customized R&D and Production Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Customized R&D and Production Services as of 2024)
Figure 16. The Top 10 and 5 Players Market Share by Pharmaceutical Customized R&D and Production Services Revenue in 2024
Figure 17. North America Pharmaceutical Customized R&D and Production Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Pharmaceutical Customized R&D and Production Services Market Share by Country (2020-2031)
Figure 19. United States Pharmaceutical Customized R&D and Production Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. Canada Pharmaceutical Customized R&D and Production Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Europe Pharmaceutical Customized R&D and Production Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Pharmaceutical Customized R&D and Production Services Market Share by Country (2020-2031)
Figure 23. Germany Pharmaceutical Customized R&D and Production Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. France Pharmaceutical Customized R&D and Production Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. U.K. Pharmaceutical Customized R&D and Production Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Italy Pharmaceutical Customized R&D and Production Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Russia Pharmaceutical Customized R&D and Production Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Nordic Countries Pharmaceutical Customized R&D and Production Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Asia-Pacific Pharmaceutical Customized R&D and Production Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Pharmaceutical Customized R&D and Production Services Market Share by Region (2020-2031)
Figure 31. China Pharmaceutical Customized R&D and Production Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Japan Pharmaceutical Customized R&D and Production Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. South Korea Pharmaceutical Customized R&D and Production Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Southeast Asia Pharmaceutical Customized R&D and Production Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. India Pharmaceutical Customized R&D and Production Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Australia Pharmaceutical Customized R&D and Production Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Latin America Pharmaceutical Customized R&D and Production Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Pharmaceutical Customized R&D and Production Services Market Share by Country (2020-2031)
Figure 39. Mexico Pharmaceutical Customized R&D and Production Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Brazil Pharmaceutical Customized R&D and Production Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Pharmaceutical Customized R&D and Production Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Pharmaceutical Customized R&D and Production Services Market Share by Country (2020-2031)
Figure 43. Turkey Pharmaceutical Customized R&D and Production Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Saudi Arabia Pharmaceutical Customized R&D and Production Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. UAE Pharmaceutical Customized R&D and Production Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Haixiang Pharmaceutical Revenue Growth Rate in Pharmaceutical Customized R&D and Production Services Business (2020-2025)
Figure 47. Innovent Biologics Revenue Growth Rate in Pharmaceutical Customized R&D and Production Services Business (2020-2025)
Figure 48. Betta Pharmaceuticals Revenue Growth Rate in Pharmaceutical Customized R&D and Production Services Business (2020-2025)
Figure 49. Jiuzhou Pharmaceutical Revenue Growth Rate in Pharmaceutical Customized R&D and Production Services Business (2020-2025)
Figure 50. Puluo Pharmaceutical Revenue Growth Rate in Pharmaceutical Customized R&D and Production Services Business (2020-2025)
Figure 51. Menohua Revenue Growth Rate in Pharmaceutical Customized R&D and Production Services Business (2020-2025)
Figure 52. Tianyu shares Revenue Growth Rate in Pharmaceutical Customized R&D and Production Services Business (2020-2025)
Figure 53. Aoxiang Pharmaceutical Revenue Growth Rate in Pharmaceutical Customized R&D and Production Services Business (2020-2025)
Figure 54. Hetero Revenue Growth Rate in Pharmaceutical Customized R&D and Production Services Business (2020-2025)
Figure 55. CellMark Revenue Growth Rate in Pharmaceutical Customized R&D and Production Services Business (2020-2025)
Figure 56. R&D Systems Revenue Growth Rate in Pharmaceutical Customized R&D and Production Services Business (2020-2025)
Figure 57. Porton Pharmaceuticals Revenue Growth Rate in Pharmaceutical Customized R&D and Production Services Business (2020-2025)
Figure 58. Kai Laiying Revenue Growth Rate in Pharmaceutical Customized R&D and Production Services Business (2020-2025)
Figure 59. Smart Life Revenue Growth Rate in Pharmaceutical Customized R&D and Production Services Business (2020-2025)
Figure 60. Notai Biotech Revenue Growth Rate in Pharmaceutical Customized R&D and Production Services Business (2020-2025)
Figure 61. Aurobindo Pharma Revenue Growth Rate in Pharmaceutical Customized R&D and Production Services Business (2020-2025)
Figure 62. Lonza Group Revenue Growth Rate in Pharmaceutical Customized R&D and Production Services Business (2020-2025)
Figure 63. Catalent Inc. Revenue Growth Rate in Pharmaceutical Customized R&D and Production Services Business (2020-2025)
Figure 64. Recipharm AB Revenue Growth Rate in Pharmaceutical Customized R&D and Production Services Business (2020-2025)
Figure 65. Jubilant Pharmova Ltd Revenue Growth Rate in Pharmaceutical Customized R&D and Production Services Business (2020-2025)
Figure 66. Patheon Inc. (Thermo Fisher Scientific Inc.) Revenue Growth Rate in Pharmaceutical Customized R&D and Production Services Business (2020-2025)
Figure 67. Boehringer Ingelheim Group Revenue Growth Rate in Pharmaceutical Customized R&D and Production Services Business (2020-2025)
Figure 68. Pfizer CentreSource Revenue Growth Rate in Pharmaceutical Customized R&D and Production Services Business (2020-2025)
Figure 69. Baxter International Inc. Revenue Growth Rate in Pharmaceutical Customized R&D and Production Services Business (2020-2025)
Figure 70. Lonza Group Revenue Growth Rate in Pharmaceutical Customized R&D and Production Services Business (2020-2025)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed